Watts Ryan J.

CIK 00017243101 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001724310

Recent Transactions

50 trades

Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2026-01-06$16.50/sh−35,198→ 296,833 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2026-01-03+236,880→ 236,880 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2026-01-03+78,960→ 332,031 total
Gift
Denali Therapeutics Inc.$DNLI
Common Stock
2025-09-03−50,000→ 2,152,604 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2025-07-09−455,282→ 622,809 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2025-07-09$5.28/sh+40,000→ 748,353 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2025-07-09$15.00/sh−495,282→ 253,071 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2025-07-09$0.68/sh+455,282→ 708,353 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2025-07-09−40,000→ 20,369 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2025-01-07$20.81/sh−7,650→ 253,071 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2025-01-06$20.22/sh−29,266→ 260,721 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2025-01-03+54,180→ 289,987 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2025-01-03+162,540→ 162,540 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-10-18−40,000→ 1,078,091 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2024-10-18$0.68/sh+40,000→ 275,807 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-10-18$27.69/sh−40,000→ 235,807 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-08-20$23.79/sh−2,260→ 235,807 total
Gift
Denali Therapeutics Inc.$DNLI
Common Stock
2024-03-29−40,000→ 2,202,604 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-02-13$17.29/sh−9,589→ 238,067 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-01-09$19.78/sh−7,818→ 2,268,363 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-01-05$19.43/sh−17,483→ 2,276,181 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-01-03+268,560→ 268,560 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2024-01-03+89,520→ 272,957 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-08-21$22.59/sh−2,309→ 2,242,604 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-08-10−2,526→ 1,118,091 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-08-10$25.03/sh−2,526→ 2,239,913 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2023-08-10$0.68/sh+2,526→ 2,242,439 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2023-06-16$0.68/sh+50,000→ 2,289,913 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-06-16−50,000→ 1,120,617 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-06-16$31.40/sh−50,000→ 2,239,913 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-04-21−24,800→ 1,170,617 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-04-21$25.15/sh−24,800→ 2,239,913 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2023-04-21$0.68/sh+24,800→ 2,264,713 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2023-04-20$0.68/sh+200→ 2,240,113 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-04-20−200→ 1,195,417 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-04-20$25.00/sh−200→ 2,239,913 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-02-13−25,000→ 1,195,617 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-02-13$30.08/sh−25,000→ 2,239,913 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2023-02-13$0.68/sh+25,000→ 2,264,913 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-02-13$30.09/sh−8,815→ 2,239,913 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-02-10−25,000→ 1,220,617 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-02-10$29.10/sh−25,000→ 2,229,031 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2023-02-10$0.68/sh+25,000→ 2,254,031 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-02-09$30.59/sh−3,433→ 2,229,031 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-01-05$28.44/sh−4,800→ 2,223,664 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-01-04$28.73/sh−5,029→ 2,213,464 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2023-01-03+82,240→ 231,934 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-01-03+246,720→ 246,720 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-08-19$33.22/sh−2,404→ 2,202,993 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-02-11$34.72/sh−9,491→ 2,129,648 total

Companies

Denali Therapeutics Inc.
Director, President and CEO
$DNLI

Recent Filings

Address

C/O DENALI THERAPEUTICS INC. 161 OYSTER POINT BLVD.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov